By combining omics analyses, including genomics and transcriptomics, magnetic resonance imaging (MRI)-based brain network analysis, and brain-computer interface (BCI) technologies that utilize neural signals with NeuroAI-based big data analytics, we aim to elucidate the biological basis of key clinical symptoms shared across various brain disorders and establish a scientific foundation for symptom-based precision patient stratification and biomarker discovery.

In addition, we establish research infrastructure and collaborative networks among industry, academia, research institutes, and hospitals in emerging strategic fields of neuroscience, including NeuroAI and BCI, connecting the institute's accumulated data and research capabilities with new scientific discoveries and technologies.

Through the Korea Brain Academy, we also promote educational and academic programs and the development of specialized professionals, contributing to the dissemination of research achievements and the training of the next generation of neuroscience researchers. Ultimately, we aim to strengthen our role as a research and collaboration hub leading the utilization of national neuroscience big data and the development of future strategic technologies.